1. Role: Director. Scope: College. Description: Director of Strategic Partnerships and Program Development in the Graduate College.Responsibilities:Develop initiatives to establish scholarship funds for graduate students.Organize education seminars and/or workshops for students. Date: 1969.
Anne Kasus-Jacobi, Ph.D.
Associate Professor
Pharmaceutical Sciences
Phone (405) 271-1484
Alt Phone (405) 637-3432
Fax (405) 271-7505
Office CPB 255
Summary
My lab currently focuses on two research projects that aim at uncovering the molecular mechanisms by which the cationic antimicrobial protein CAP37 is affecting (1) corneal wound healing and (2) neuroinflammation, with the long-term goal of developing peptide therapeutics for ocular injuries and Alzheimer’s disease.
In collaboration with Dr. Pereira, we found that the antimicrobial and inflammatory mediator CAP37, and several CAP37-derived antimicrobial peptides could promote corneal wound healing andclearance of corneal infections in vivo. Recently, my lab started to focus on the identification of the molecular mechanisms involved in the wound healing activity of CAP37 and CAP37-derived peptides. The goal of this project is the identification of the receptor and intracellular signaling molecules mediating CAP37-induced corneal wound healing.
In collaboration with Dr. Pereira, we also explored the potential roles of CAP37 in diseases linked to aging and chronic inflammation. We have shown increased expression of CAP37 in the neurons of patients with Alzheimer’s disease, and an effect of CAP37 on two important players of this disease; amyloid beta and the Receptor for Advanced Glycation End-products (RAGE). To pursue this line of research, my lab is currently exploring the structural aspects of CAP37’s effects on RAGE and amyloid beta. This project, funded by the Oklahoma COBRE in Structural Biology, was started in 2017.
Publications & Presentations
- 6. Griffith G L, Kasus-Jacobi A, Pereira A. Bioactive Antimicrobial Peptides as Therapeutics for Corneal Wounds and Infections. Advances in wound care. 2017; 6 : 175-190
7. Kasus-Jacobi A, Griffith G L, Lerner M, Pereira A. Effect of Cationic Antimicrobial Protein CAP37 on Cytokine Profile during Corneal Wound Healing. Journal of ocular diseases and therapeutics. 2017; 5 : 19-27
8. Stock A J, Kasus-Jacobi A, Wren J, Sjoelund V, Prestwich G, Pereira H A. The role of neutrophil proteins on the amyloid beta-RAGE axis. Plos One. 2016
9. Brock A J, Kasus-Jacobi A, Lerner M, Logan S, Adesina A M, Pereira A. The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease. Histochemistry and cell biology. 2015; 144 : 293-308
10. Kasus-Jacobi A, Noor-Mohammadi S, Griffith G L, Hinsley H, Mathias L, Pereira A. A multifunctional peptide based on the neutrophil immune defense molecule, CAP37, has antibacterial and wound-healing properties. Journal of leukocyte biology. 2015; 97 : 341-50
Grants
- 11. Development of Bioactive Peptides for the Inhibition of Neuroinflammation and Neurotoxicity Induced by Amyloid-beta. Non-federal. Start Date: 2020. End Date: 2021.
12. Novel Peptide Therapeutic for Corneal Wound Healing and Infections. Misc Non-Federal. Start Date: 2019. End Date: 2020.
13. Development of Bioactive Peptides for the Inhibition of Neuroinflammation and Neurotoxicity Induced by Amyloid-beta. Non-federal. Start Date: 2019. End Date: 2019.
14. Wound Healing Mechanisms Modulated by Novel Antimicrobial Peptides. NIH. Start Date: 2016. End Date: 2019.
15. Structural Approach to Define New Functional Activities of Neutrophil Protein CAP37 in Neurodegenerative Diseases. NIH. Start Date: 2017. End Date: 2019.
Awards and Honors
- 1. NIH. MBArC-REACH Second tranche. Date: 2023.
2. OUHSC College of Pharmacy. Seed Grant. Date: 2022.
3. OCAST. OCAST-OARS. Date: 2022.
4. OUHSC/Office of Technology Development. Growth Fund. Date: 2021.
5. NIH. MBArC-REACH First tranche. Date: 2021.
Education
- 1. Degree: Ph D. University of Paris XI. Date: 1998.
2. Degree: MS. University of Paris VII. Date: 1993.
3. Degree: BS. University of Paris VII. Date: 1992.